Navigation Links
Linking EudraCT and ClinicalTrials.gov Records Provides Huge Benefit
Date:11/15/2011

LONDON, November 15, 2011 /PRNewswire/ --

EvaluatePharma Ltd, a leading source for life science sector analysis and the first to supply consensus forecasts of global drug sales, announced today the launch of its new clinical trial intelligence service, EP Clinical Trials[SM]. By linking EudraCT and ClinicalTrials.gov records, the new service delivers a unique synthesis of clinical trials information that will greatly benefit companies as they manage clinical trial strategies, plan clinical development programs, or seek out investment opportunities.

"Currently 52% (15,900+ trial records) of the EudraCT clinical trial data, originally released in March 2011, has been made public, and we have successfully linked half of this data via NCT-ID reference number to ClinicalTrials.gov records," said Anthony Raeside, Head of Research at EvaluatePharma®,"Our goal is to continue to make the data as meaningful and valuable as possible by indexing, linking, and revealing previously un-recognised synergies between the public clinical trial directories."

By linking the two leading sources of clinical trial records, a few examples of additional information benefit includes:

  • Enrolment numbers available for each EU country
  • Trials identified for orphan (rare disease) indications
  • Standardized technology for investigational drugs disclosed, such as biologic - gene therapy
  • Standardized pharmaceutical form such as transdermal patch
  • Ability to identify commercial company trials unique to the EudraCT site

EP Clinical Trials[SM] updated daily, also provides mapped data such as biopharmaceutical company and product information, peak and historical sales, indication, top level deal information, custom data alerts and award winning EP Vantage® commentary and analysis.

About EvaluatePharma Ltd

The research company EvaluatePharma Ltd was the first to supply consensus forecasts of global drug sales and now provides standardized worldwide financial and forecast models with consensus product sales forecasts to 2016, data on R&D pipelines, licensing deals, patent risk and M&A activity. Launched in 2007, EvaluatePharma®Alpha offers a Net Present Value (NPV) valuation service quantifying market events and the impact on product, portfolio and company valuation including the daily online news service EP Vantage®.

EvaluatePharma®, EvaluatePharma®Alpha, and EP Vantage® are services of EvaluatePharma Ltd, headquartered in London, England. In North America, EvaluatePharma Ltd is represented by EvaluatePharma USA, Inc.

http://www.evaluatepharma.com

Media Contacts:

Andrew Beaven
Marketing Director, EvaluatePharma Ltd
T: +44(0)20-7539-1818
E: andrewb@evaluatepharma.com
EvaluatePharma Ltd
11-29 Fashion Street
London
E1 6PX
United Kingdom

Christine Lindgren
EvaluatePharma USA, Inc
T: +1-617-573-9458
E: christinel@evaluatepharma.com
EvaluatePharma Ltd
15 Broad St.
Suite 401
Boston, MA
02109


'/>"/>
SOURCE EvaluatePharma Ltd
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Study Linking Increased Risk of Death to Severe Psoriasis a Call to Action
2. New Study Linking High Normal Blood Pressure to Significant Cardiovascular Risk
3. Interleukin Genetics Presents Research Linking Vertebral Fractures to Gene Variations in Asian Women With Osteoporosis
4. Glycotex, Inc. Releases Final Phase II Clinical Trials Results in the Clinicaltrials.gov Database and Announces the Results of the Mechanism of Action Study for its Product Candidate GLYC-101
5. Clinical Care Options Announces Addition of ClinicalTrials.gov Database to CCO inPractice™ Point-of-Care Resource
6. Vicus Therapeutics Records Last Patient Visit of Phase 2, VT-122 Trial for the Treatment of Cachexia in Patients With Advanced Lung Cancer
7. Aprima and MednetwoRx Partner to Provide Electronic Health Records and Remote Hosting Option to Physician Practices
8. Praxis Electronic Medical Records Announces New Version 5 With Breakthrough in EHR Documentation
9. Novalung Records 50% Growth
10. Huntington Financing Package Supports Major Regional Medical Center Electronic Medical Records Project
11. Elekta Impac Software to Demonstrate Oncology EHR Capabilities at Electronic Health Records Lab in Chicago
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 2016 Research and Markets has announced ... Diagnostic Tests" report to their offering. ... The World Market for Companion Diagnostics covers ... Market analysis in the report includes the following: ... Diagnostic Kits) by Region (N. America, EU, ROW), 2015-2020 ...
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ., ... developing innovative inhaled drugs, announced today that it was ... Investments reconstituted its comprehensive set of U.S. and ... "This is an important milestone for Pulmatrix," said Chief ... shareholder awareness of our progress in developing drugs for ...
(Date:6/24/2016)... KNOXVILLE, Tenn. , June 24, 2016 /PRNewswire/ ... market providing less invasive and more durable cerebrospinal ... million in funding.  The Series-A funding is led ... the Lighthouse Fund, and other private investors.  Arkis, ... less-invasive neurosurgical instrumentation and the market release of ...
Breaking Medicine Technology:
(Date:6/26/2016)... North Carolina (PRWEB) , ... June 26, 2016 , ... ... release of a new product that was developed to enhance the health of felines. ... for centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... ... 25, 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due to ... a new, often overlooked aspect of head lice: the parasite’s ability to live away from ... common occurrence, but a necessary one in the event that lice have simply gotten out ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of ... recognition of their exemplary accomplishments in worksite health promotion. , The Wellness at Work ... Symposium at the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses ...
(Date:6/24/2016)... ... 2016 , ... Marcy was in a crisis. Her son James, eight, was out of control. ... and physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. ... rocks at my other children and say he was going to kill them. If ...
(Date:6/24/2016)... ... ... makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair Minimum ... by 2020 and then adjusting it yearly to increase at the same rate as the ... wage floor does not erode again, and make future increases more predictable. , The company ...
Breaking Medicine News(10 mins):